HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

2016243 citationsJournal Article

Authors

Angela N. Bartley · Mercy Hospital

M. Kay Washington · Vanderbilt University

Christina B. Ventura

Nofisat Ismaila · American Society of Clinical Oncology

Carol Colasacco

Al B. Benson

Alfredo Carrato · Hospital Universitario Ramón y Cajal

Margaret L. Gulley · University of North Carolina at Chapel Hill

Abstract

- This guideline provides specific recommendations for assessment of HER2 in patients with advanced GEA while addressing pertinent technical issues and clinical implications of the results.

Topics & Keywords

Gastric Cancer Management and Outcomes HER2/EGFR in Cancer Research Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: Archives of Pathology & Laboratory Medicine

Volume 140, Issue 12, pp. 1345-1363

DOI: 10.5858/arpa.2016-0331-cp

Field-Weighted Citation Impact: 11.30